CAPILLARY
Capillary Technologies India Limited (NSE: CAPILLARY) breaks out, gains 5% intraday
Capillary Technologies India Limited (NSE: CAPILLARY) stock breaks out of its 6M resistance trendline, gaining 5% intraday to ₹521.35.
Capillary Technologies India Limited (CAPILLARY) breaks out, gaining +5% to ₹521.35 on the NSE on 04 Aug 2026. This move comes as the stock cleared its 6-month resistance trendline, which was previously approaching resistance at ₹512. Capillary Technologies, a player in the technology sector focused on software infrastructure, has shown a company-specific move today, not necessarily aligned with broader sector momentum.
Technical setup — trendlines & DMA
From a technical standpoint, Capillary Technologies is currently trading above its 6-month support trendline, which ends at ₹466.56, indicating a solid floor beneath the current price. The resistance trendline, previously at ₹511.86, has been broken, signaling a potential shift in momentum. The 50-day moving average (DMA) at ₹504.1 is below the 200-DMA at ₹561.1, suggesting a bearish trend. However, the stock’s position within its 52-week range, currently in the lower third, implies there may be room for further upside if the breakout sustains.
Snapshot: ₹521.35 on 2026-08-04 (chart frozen at publication)
Fundamentals & business context
On the fundamental side, Capillary Technologies presents a mixed picture. With a PE ratio of 72.2 and profit margins at 7.1%, the valuation appears stretched relative to current earnings, especially given the revenue CAGR of 42.2%. This suggests the market may be pricing in future growth expectations. Institutional ownership stands at 20.6%, indicating a cautious but present interest from smart money. There was no specific NSE catalyst today, but the breakout could be attributed to broader market sentiment or sector-specific trends.
Algorithmic scorecard
The overall algorithmic scorecard for Capillary Technologies reflects a balanced but cautious outlook. Two of the strongest signals are the excellent revenue CAGR of 42.2%, indicating robust top-line growth, and the very low debt levels with a D/E ratio of 0.00, showcasing strong financial health. On the flip side, the low profit margin of 7.1% and the negligible dividend yield of 0% represent significant risks. The low margin leaves little room for error, while the absence of dividend income may deter income-focused investors.
Company outlook
Management’s forward guidance for Capillary Technologies is optimistic yet cautious. They expect EBITDA margins to remain sustainable, with a potential dip due to the SessionM acquisition. The core organic business is projected to achieve a steady-state EBITDA margin of 25-30%. Revenues are anticipated to surpass INR 1,000-1,050 crores in FY27, driven by both the SessionM acquisition and organic growth. SessionM is expected to significantly contribute to revenue and EBITDA in the coming years. The company plans to maintain a 115% NRR on the organic business and target upgrades on the inorganic side to enhance margins. Additionally, an AI-led platform is in development to upgrade customers from acquired stacks to Capillary, aiming to accelerate margin improvements and integrations.
Get all details on CAPILLARY — P&L, peers, shareholding and more on TradeAlone.
CAPILLARY
Capillary Technologies India Limited Q2 Fy2027: Operating Revenue Up 51% Yoy
Capillary Technologies India Limited (CAPILLARY) reports 51% YoY growth in operating revenue for Q2 FY2027, with 103% growth in Adjusted EBITDA.
Capillary Technologies India Limited (CAPILLARY) announced its financial results for the second quarter and half year ended September 30, 2026. The company reported strong revenue growth of 51% year-on-year (43% in constant currency) and 103% growth in Adjusted EBITDA for the quarter ended September 30, 2026. This growth reflects strong expansion across existing customers, rising contributions from new annual contract value, and the inclusion of revenues from SessionM, Capillary’s most recent acquisition completed in May 2026.
Quarterly Performance
For Q2 FY2027, compared to the same quarter last year, the company reported:
- Operating Revenue of ₹ 2,713.5 Mn. vs. ₹ 1,793.3 Mn. (+51% YoY; +43% YoY CC)
- Adjusted EBITDA of ₹ 448.6 Mn. vs. ₹ 220.8 Mn. (+103% YoY)
- PAT of ₹ 219.2 Mn. vs. ₹ 2.9 Mn. (+7,505% YoY)
Half-Year Performance
For H1 FY2027, compared to the same period last year, the company reported:
- Operating Revenue of ₹ 5,280.0 Mn. vs. ₹ 3,592.2 Mn. (+47% YoY; +38% YoY CC)
- Adjusted EBITDA of ₹ 888.8 Mn. vs. ₹ 410.6 Mn. (+116% YoY)
- PAT of ₹ 123.7 Mn. vs. ₹ 10.3 Mn. (+1,097% YoY)
Commenting on Q2 FY2027 results, Aneesh Reddy Boddu, Founder, MD & CEO, said, “We delivered another strong quarter, driven by continued Net Revenue Retention (NRR) expansion and new enterprise wins across global markets. SessionM, which we acquired from Mastercard last quarter, is performing as planned and has achieved breakeven; our integration plans are on track. Artificial Intelligence has become a major tailwind for our business with aiRA and our broader AI capabilities underpinning key new ACV wins this quarter which are up 79% YoY on a TTM basis (excluding an exceptional new contract value from our first entry into the healthcare vertical). We also completed our first customer migration using our AI-powered migration technology, which positions us to move acquired customers onto the Capillary platform faster and more efficiently. We are seeing strong momentum in our Order book across Geographies. Looking ahead, we remain focused on sustainable organic growth and profitability, while scaling AI across our platform, our customer migrations and our own operations.”
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Capillary Technologies India Limited
Capillary Technologies India Limited belongs to the Technology › Software – Application sector. Here’s a quick read on where the business and the stock stand today.
Capillary rises 11.0% over three months, with buying pressure holding steady. Thin margins at 5.2% leave limited room for error — any demand softness or cost spike hits the bottom line hard. 1 loss quarter(s) over five years signals earnings fragility — not chronic but worth noting. The stock holds at 30% of its 52-week range with RSI at 51. In other words, neither side has a clear edge right now. Revenue grows at 42.2% and the stock moves sideways over three months. Neither side makes a strong case. The next earnings print will likely break this stock out of its current range. Check Fundamentals of Capillary Technologies India Limited.
CAPILLARY
Capillary Technologies India Limited (capillary) Appoints Bill Swift as President, Americas
Capillary Technologies India Limited (CAPILLARY) appoints Bill Swift as President, Americas, strengthening its US leadership and growth strategy.
Capillary Technologies India Limited (CAPILLARY) announced the appointment of Bill Swift as President, Americas, on October 29, 2026. This strategic move underscores Capillary’s commitment to deepening its presence across the Americas. Swift brings nearly 30 years of experience in helping leading brands build lasting customer relationships and drive measurable business results.
Leadership Expertise
Swift previously served as CEO of Brierley, a company that pioneered in loyalty solutions. His role at Brierley+Partners, where he helped create a successful loyalty platform, has equipped him with deep insights into loyalty strategies. Since joining Capillary in 2023, Swift has been instrumental in integrating acquisitions and shaping Capillary’s growth trajectory.
Strategic Vision for Americas
In his new role, Swift will lead Capillary’s business operations across the Americas, focusing on sales, client success, and delivery. He aims to drive growth with enterprise brands in retail, hospitality, travel, airlines, and other major sectors. Swift emphasizes that loyalty should be viewed as a catalyst for growth, facilitated by technology that delivers powerful customer experiences and business results.
“Loyalty has always been about earning the right to a lasting relationship with the customer,” said Bill Swift. “The most successful brands now see loyalty as a catalyst for growth, driven by technology that delivers real business results.”
Anant Choubey, co-founder & COO of Capillary, highlighted Swift’s strategic depth and understanding of customer relationships, stating, “His leadership was essential to Brierley+Partners’ success, and he is the right leader to accelerate our growth across the Americas.”
Founded in 2012, Capillary Technologies helps brands leverage lasting customer relationships to achieve measurable growth. Its AI-powered platform integrates loyalty, data, and engagement to deliver personalized experiences, strengthening retention and growing customer lifetime value.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Capillary Technologies India Limited
Capillary Technologies India Limited belongs to the Technology › Software – Application sector. Here’s a quick read on where the business and the stock stand today.
Capillary rises 11.0% over three months, with buying pressure holding steady. Thin margins at 5.2% leave limited room for error — any demand softness or cost spike hits the bottom line hard. 1 loss quarter(s) over five years signals earnings fragility — not chronic but worth noting. The stock holds at 30% of its 52-week range with RSI at 51. In other words, neither side has a clear edge right now. Revenue grows at 42.2% and the stock moves sideways over three months. Neither side makes a strong case. The next earnings print will likely break this stock out of its current range. Check Fundamentals of Capillary Technologies India Limited.
CAPILLARY
Capillary Technologies India Limited (CAPILLARY) eases after clearing resistance, down 5% intraday
Capillary Technologies India Limited (NSE: CAPILLARY) shows pressure after breakout, moving down 5% intraday.
Capillary Technologies India Limited (CAPILLARY) pulls back from breakout highs, falling 5% to ₹530.4 on the NSE today. This retracement comes after the stock cleared a crucial 6-month resistance level at ₹512, marking a structural breakout. The pullback today is likely due to profit-taking following this breakout. Capillary Technologies operates in the technology sector, specifically in software infrastructure. Today’s move appears to be company-specific rather than a sector-wide trend, as it follows the breakout and subsequent profit-taking.
Technical setup — trendlines & DMA
The current 6-month trendline structure shows a breakout above the resistance level at ₹512, with the stock now trading 3.5% above this resistance. The 6-month support trendline is at ₹464.21, which is 12.48% below today’s price. The stock is currently trading 11% above the 50-day moving average (DMA) at ₹505.2, indicating an extended move. However, it is slightly below the 200-DMA at ₹560.7. The stock is in the lower third of its 52-week range, trading 20% above the 52-week low and 33.6% below the 52-week high, suggesting there is still room for further upside within the year.
Snapshot: ₹530.40 on 2026-08-10 (chart frozen at publication)
Fundamentals & business context
With a PE ratio of 81.7 and profit margins at 5.2%, Capillary Technologies is trading at a high valuation relative to its current earnings. The revenue CAGR of 34.0% indicates strong growth, but the thin profit margins suggest that the market may be pricing in future improvements or a potential turnaround. The 20.6% institutional ownership suggests that smart money has a moderate level of confidence in the company, though it is not overwhelmingly bullish. There is no NSE catalyst today, so the move is primarily technical.
Algorithmic scorecard
The overall algorithmic scorecard reflects a technically strong but fundamentally weak position for Capillary Technologies. The strongest signals include the revenue and profit CAGRs, which are excellent at 34.0% and 27.0%, respectively, indicating robust growth. Additionally, the very low debt level with a D/E ratio of 0.00 points to excellent financial health. On the weaker side, the low profit margin of 5.2% leaves little room for error, and the PEG ratio of 3.03 suggests the stock is overvalued relative to its growth rate. The negligible dividend yield also means there is little to no income generation from this investment.
Company outlook
Management expects EBITDA margins to remain sustainable, with a potential dip due to the SessionM acquisition. The core organic business is projected to reach a steady-state EBITDA margin of 25-30%. Revenues are anticipated to exceed INR 1,000-1,050 crores in FY27, driven by both the SessionM acquisition and organic growth. SessionM is expected to significantly contribute to revenue growth and EBITDA in the coming years. The company plans to maintain a 115% NRR on the organic business and target upgrades on the inorganic side to improve margins. An AI-led platform is in development to upgrade customers from acquired stacks to Capillary, aiming to accelerate margin improvements and integrations.
Get all details on CAPILLARY — P&L, peers, shareholding and more on TradeAlone.
-
AKUMS3 days agoAkums Drugs and Pharmaceuticals Limited (akums) Q2 FY27: Revenue Up 32%, Ebitda and PAT Surge
-
Information Technology Services3 days agoOrient Technologies Limited (orienttech) Q2 FY27: Strong Profitability on Higher Managed Services Contribution
-
Consumer Cyclical3 days agoTbo Tek Limited (tbotek) Q2 FY27: Revenue Up 53%, Adj. Ebitda at ₹152 Crores
-
Industrials3 days agoAmara Raja Energy & Mobility Limited (are&m) Q2 FY27: Revenue Up 13%
-
Consumer Cyclical3 days agoSheela Foam Limited Q2 & H1 FY27 Results: Revenue Surpasses ₹1,000 Cr, PAT Up 6.6x Yoy
-
Apparel Retail3 days agoArvind Fashions Limited Announces Highest Ever Revenue and Ebitda, Delivers Revenue Growth of 10.0% and Ebitda Growth of 15.5%
-
Auto Parts3 days agoJay Bharat Maruti Limited Q2 FY’27 Results: PAT Up 72.59%, Revenue Grows 41.97%
-
RAYMONDREL3 days agoRaymond Realty Limited (raymondrel) Reaffirms Strong Governance Framework, Highlights Business Momentum and Audit Continuity